Literature DB >> 16774869

Airflow distribution in the human lung and its influence on particle deposition.

B Asgharian1, O T Price.   

Abstract

Realistic descriptions of lung geometry and physiology are the primary determinants of accurate predictions of inhaled particle deposition and distribution in the human lung. While there have been considerable efforts devoted to geometry reconstruction, little attention has been given to lung ventilation as applied to particle deposition applications. Models of lung ventilation based on pressure differential between extrathoracic airways and the pleural cavity were developed and used to calculate lobar and regional deposition of particles in the human lung. Local airflow in the lung varied in accordance with regional physiological properties. Calculations showed that airflow rate entering each lobe was different for compliant and noncompliant lung models and similar for uniform and nonuniform lung expansions. Regional particle deposition predictions were almost identical between the two compliance models. However, differences in lobar depositions were observed. The coupled lung ventilation and deposition models can be used in site-specific deposition predictions of inhaled particles in the human lungs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774869     DOI: 10.1080/08958370600748687

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  17 in total

1.  Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.

Authors:  P Worth Longest; Geng Tian; Ross L Walenga; Michael Hindle
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

2.  Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.

Authors:  P Worth Longest; Geng Tian; Navvab Khajeh-Hosseini-Dalasm; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-04-15       Impact factor: 2.849

Review 3.  Nanoparticles in Daily Life: Applications, Toxicity and Regulations.

Authors:  Ritu Gupta; Huan Xie
Journal:  J Environ Pathol Toxicol Oncol       Date:  2018       Impact factor: 3.567

Review 4.  In silico models of aerosol delivery to the respiratory tract - development and applications.

Authors:  P Worth Longest; Landon T Holbrook
Journal:  Adv Drug Deliv Rev       Date:  2011-05-27       Impact factor: 15.470

5.  Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.

Authors:  Geng Tian; Michael Hindle; Sau Lee; P Worth Longest
Journal:  Pharm Res       Date:  2015-05-06       Impact factor: 4.200

6.  Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.

Authors:  Ross L Walenga; P Worth Longest
Journal:  J Pharm Sci       Date:  2016-01-13       Impact factor: 3.534

7.  Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways.

Authors:  Geng Tian; Philip Worth Longest; Guoguang Su; Michael Hindle
Journal:  Ann Biomed Eng       Date:  2010-12-09       Impact factor: 3.934

8.  Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry.

Authors:  Günter Oberdörster; Vincent Castranova; Bahman Asgharian; Phil Sayre
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015       Impact factor: 6.393

9.  Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery.

Authors:  Ross L Walenga; Geng Tian; P Worth Longest
Journal:  J Biomech Eng       Date:  2013-09       Impact factor: 2.097

10.  Murine pulmonary responses after sub-chronic exposure to aluminum oxide-based nanowhiskers.

Authors:  Andrea Adamcakova-Dodd; Larissa V Stebounova; Patrick T O'Shaughnessy; Jong Sung Kim; Vicki H Grassian; Peter S Thorne
Journal:  Part Fibre Toxicol       Date:  2012-06-19       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.